Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 102451-102500 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04166604
LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy
PHASE2Active, not recruiting
176 participants
Started: May 20, 2020 · Completed: Nov 30, 2025
1 condition1 sponsor22 locations
NCT06177002
SARS-CoV-2, TESTOSTERONE AND MALE FRAGILITY
N/ARecruiting
2,000 participants
Started: May 19, 2020 · Completed: May 18, 2025
3 conditions1 sponsor1 location
NCT05713994
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
N/ARecruiting
300 participants
Started: May 19, 2020 · Completed: Dec 30, 2025
1 condition6 sponsors2 locations
NCT04332341
Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
EARLY_PHASE1Recruiting
20 participants
Started: May 19, 2020 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05441969
In Vivo Cortical Excitability Modulation in Major Depressive Disorder
N/ARecruiting
90 participants
Started: May 19, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04169204
Very Old Intensive Care Patients - Perfusion
N/AActive, not recruiting
47 participants
Started: May 19, 2020 · Completed: May 30, 2024
3 conditions1 sponsor1 location
NCT04241185
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
PHASE3Active, not recruiting
520 participants
Started: May 19, 2020 · Completed: Nov 1, 2031
1 condition1 sponsor126 locations
NCT04237623
GM-CSF With Post-Transplant Cyclophosphamide
PHASE2Recruiting
38 participants
Started: May 18, 2020 · Completed: Sep 18, 2025
1 condition1 sponsor1 location
NCT04190589
Prospective Study of Extended Robotic Right Hemicolectomy With Complete Mesocolic Excision for Cancer
NARecruiting
40 participants
Started: May 18, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04186520
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
PHASE1/PHASE2Recruiting
100 participants
Started: May 18, 2020 · Completed: Jun 1, 2028
8 conditions1 sponsor1 location
NCT04302116
Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm
NARecruiting
250 participants
Started: May 18, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04364555
Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.
PHASE2/PHASE3Active, not recruiting
90 participants
Started: May 18, 2020 · Completed: Dec 31, 2025
1 condition3 sponsors2 locations
NCT04519320
Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae
NAActive, not recruiting
140 participants
Started: May 18, 2020 · Completed: Aug 18, 2025
1 condition1 sponsor1 location
NCT04361162
Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer
PHASE2Active, not recruiting
30 participants
Started: May 18, 2020 · Completed: Oct 31, 2026
2 conditions2 sponsors3 locations
NCT04491292
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce
N/ARecruiting
20,000 participants
Started: May 18, 2020 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT04328662
A Study of Ninlaro in Real World Clinical Practice in China
N/AActive, not recruiting
482 participants
Started: May 18, 2020 · Completed: Mar 30, 2026
2 conditions1 sponsor28 locations
NCT04176718
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
PHASE2Recruiting
43 participants
Started: May 18, 2020 · Completed: May 31, 2028
4 conditions3 sponsors3 locations
NCT04067505
Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study
PHASE3Recruiting
224 participants
Started: May 18, 2020 · Completed: Dec 31, 2024
1 condition9 sponsors9 locations
NCT05374044
Establishment of MRI Model for pTRG in Rectal Cancer With Establishment of
N/AActive, not recruiting
385 participants
Started: May 18, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors3 locations
NCT04495790
AIMS Cancer Outcomes Study
N/ARecruiting
500 participants
Started: May 18, 2020 · Completed: Dec 31, 2030
5 conditions1 sponsor1 location
NCT04291261
Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease
PHASE2Active, not recruiting
24 participants
Started: May 18, 2020 · Completed: Jun 30, 2025
1 condition4 sponsors4 locations
NCT04217551
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
NAActive, not recruiting
1,158 participants
Started: May 18, 2020 · Completed: Sep 5, 2025
3 conditions5 sponsors76 locations
NCT04188405
Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia
PHASE2Active, not recruiting
20 participants
Started: May 17, 2020 · Completed: Nov 30, 2025
7 conditions1 sponsor1 location
NCT05168631
Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
N/AActive, not recruiting
88 participants
Started: May 16, 2020 · Completed: Mar 15, 2025
2 conditions1 sponsor7 locations
NCT04310787
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
N/ARecruiting
300 participants
Started: May 15, 2020 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT04768127
Adipositas Care & Health Therapy
NAActive, not recruiting
586 participants
Started: May 15, 2020 · Completed: Dec 31, 2025
2 conditions13 sponsors7 locations
NCT05218811
Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach
NARecruiting
150 participants
Started: May 15, 2020 · Completed: May 15, 2041
1 condition1 sponsor1 location
NCT05053945
Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
N/ARecruiting
260 participants
Started: May 15, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor2 locations
NCT04426669
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
PHASE1/PHASE2Active, not recruiting
20 participants
Started: May 15, 2020 · Completed: Jan 31, 2026
11 conditions2 sponsors1 location
NCT04263038
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
PHASE4Recruiting
276 participants
Started: May 15, 2020 · Completed: May 31, 2026
9 conditions6 sponsors39 locations
NCT04392206
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
PHASE1Recruiting
15 participants
Started: May 15, 2020 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT04297605
Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2
PHASE1Active, not recruiting
28 participants
Started: May 15, 2020 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT04428671
Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer
PHASE1Recruiting
20 participants
Started: May 15, 2020 · Completed: Oct 1, 2031
2 conditions2 sponsors1 location
NCT04349436
A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies
PHASE1/PHASE2Recruiting
65 participants
Started: May 15, 2020 · Completed: Jan 31, 2028
4 conditions1 sponsor28 locations
NCT04380077
Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics
NAActive, not recruiting
150 participants
Started: May 15, 2020 · Completed: Jan 21, 2025
1 condition1 sponsor1 location
NCT04523376
Pilot Study PBSCT with TCRab Depletion for Hemoglobinopathies
NAActive, not recruiting
9 participants
Started: May 14, 2020 · Completed: Jun 1, 2027
2 conditions1 sponsor1 location
NCT04299113
Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma
PHASE1Active, not recruiting
38 participants
Started: May 14, 2020 · Completed: May 22, 2027
1 condition3 sponsors1 location
NCT04300101
Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)
N/ARecruiting
300 participants
Started: May 14, 2020 · Completed: May 31, 2028
1 condition1 sponsor4 locations
NCT04150614
BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron
PHASE4Recruiting
90 participants
Started: May 14, 2020 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT04674423
The Effectiveness and Safety of Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase and Significant Liver Injury.
PHASE4Recruiting
40 participants
Started: May 14, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04531644
Double Stimulation in Women With Low Prognosis in ART
NARecruiting
100 participants
Started: May 14, 2020 · Completed: Mar 30, 2024
1 condition3 sponsors1 location
NCT04201106
A Neuroimaging Study of Open-label Placebo in Depressed Adolescents
NAActive, not recruiting
16 participants
Started: May 14, 2020 · Completed: Dec 30, 2032
1 condition2 sponsors1 location
NCT03918460
ANEUFIX for Endoleak Type II Repair
NARecruiting
40 participants
Started: May 13, 2020 · Completed: Feb 28, 2026
2 conditions2 sponsors9 locations
NCT04510025
Capturing MultiORgan Effects of COVID-19
N/ARecruiting
750 participants
Started: May 13, 2020 · Completed: May 1, 2026
2 conditions1 sponsor1 location
NCT06226519
Integrated PET/MRI and Germline Variants to Differentiate Brain Tumopr Recurrence From Iatrogenicchanges in Children
N/ARecruiting
60 participants
Started: May 13, 2020 · Completed: May 13, 2024
1 condition1 sponsor1 location
NCT04020536
Real World Study of Classic Infectious Disease
N/ARecruiting
10,000 participants
Started: May 13, 2020 · Completed: Jun 1, 2029
3 conditions33 sponsors1 location
NCT04419519
Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax
PHASE2Recruiting
80 participants
Started: May 13, 2020 · Completed: May 31, 2026
2 conditions2 sponsors9 locations
NCT03961672
Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PHASE2Active, not recruiting
15 participants
Started: May 13, 2020 · Completed: Nov 5, 2025
4 conditions2 sponsors3 locations
NCT03993262
Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis
PHASE2Recruiting
50 participants
Started: May 13, 2020 · Completed: Dec 31, 2026
1 condition2 sponsors17 locations
NCT04221555
Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma
PHASE2Recruiting
68 participants
Started: May 13, 2020 · Completed: Apr 30, 2025
1 condition1 sponsor1 location